Trial Site Detail

 

Drug:
Nilotinib and Imatinib
Trial:
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Wake Forrest

Medical Center Boulevard     
Winston-Salem , NC 27157
USA

 

Principal Investigator:
 Paul Savage, M.D.
Contact:
 Judy Lovelace, RN 336-713-6928 jlovelace@wfubmc.edu Paul Savage, MD 336-716-7975
Activation Status of this Site:
 Closed
Notes about this Site:
Wake Forrest Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.